Scarica l'app Stockscreener
92.16
0.25%
-0.19
Precedente Chiudi:
$92.35
Aprire:
$91.74
Volume 24 ore:
147.25K
Relative Volume:
0.28
Capitalizzazione di mercato:
$907.13M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-0.34%
1M Prestazione:
+1.94%
6M Prestazione:
+2.97%
1 anno Prestazione:
+0.88%
Intervallo 1D:
$91.55
$92.26
Intervallo di 1 settimana:
$90.74
$92.62
Portata 52W:
$77.67
$95.03
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Nome
Vaneck Pharmaceutical Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta PPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
92.14 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
334.93 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
681.45 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.79 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
253.94 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
629.56 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Borsa (PPH) Ultime notizie
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - Benzinga
PPH: The Big Pharma ETF (NASDAQ:PPH) - Seeking Alpha
Is VanEck Pharmaceutical (PPH) the Best Healthcare ETF to Buy? - Insider Monkey
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? - sharewise.com
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - MSN
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - The Globe and Mail
Pharmaceutical ETF on track for best week since 2020 - MarketWatch
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Unusually-High Trading Volume Following Dividend Announcement - Defense World
Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End - MSN
Headlines Boost Pharma Stocks. What the Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Say - Barron's
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
Big Pharma rebounds despite Trump’s latest tariff threat - Seeking Alpha
Biopharma Stocks Rally After Trump Threatens 100% Pharmaceuticals Tariff - inkl
President Trump's 100% Tariff Threat: What It Means For Your Pharma Portfolio - Seeking Alpha
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - The Globe and Mail
PPH: Excellent Pharmaceutical ETF, But Bad Timing To Invest (NASDAQ:PPH) - Seeking Alpha
How Trump's Drug Pricing Policies Could Trigger An Epic Pharma Collapse - Seeking Alpha
Belpointe Asset Management LLC Takes $528,000 Position in VanEck Pharmaceutical ETF $PPH - Defense World
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - sharewise.com
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - sharewise.com
Pharma stocks higher as Trump backs down from 250% tariff threat - Seeking Alpha
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - The Globe and Mail
LPL Financial LLC Cuts Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
4. SPDR S&P Pharmaceuticals ETF (ARCA:XPH) - Investing News Network
5 Biggest Pharmaceutical ETFs in 2025 - Nasdaq
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - The Globe and Mail
Markets Shrug as Chip and Pharma Stocks Navigate Trump's New Tariff Blitz - Money Morning
Envestnet Asset Management Inc. Reduces Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Cetera Investment Advisers Has $3.16 Million Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
J&J leads big pharma higher after earnings despite Trump’s latest tariff threat - MSN
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook - MSN
ETFs To Gain On JNJ's Solid Q1 Earnings & Upbeat Outlook - Barchart.com
Vaneck Pharmaceutical Etf Azioni (PPH) Dati Finanziari
Non sono disponibili dati finanziari per Vaneck Pharmaceutical Etf (PPH). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.17%
0.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):